← Back to Clinical Trials
RecruitingNCT06029621

Robot-assisted vs VATS for Thymoma

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionThymoma
SponsorShanghai Pulmonary Hospital, Shanghai, China
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment304
SexALL
Min Age18 Years
Max Age75 Years
Start Date2023-11-20
Completion2030-09-19
Interventions
RATS for ThymectomyVATS for Thymectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study is to explore the advantages of robot-assisted thymectomy in long-term survival benefits and short-term clinical efficacy compared with video-assisted thoracoscopic thymectomy based on a multi-center, prospective, randomized controlled clinical trial.

Eligibility Criteria

Inclusion Criteria: 1. ) The age of the subjects on the day of signing the informed consent was ≥ 18 years old and \< 75 years old, regardless of gender ; 2. ) Chest thin-layer CT and MR showed anterior mediastinal space-occupying lesions, combined with relevant hematological indicators, the patient was clinically diagnosed as a thymic epithelial tumor with or without myasthenia gravis ( MG ) symptoms. 3. ) need to accept thymectomy surgery ; 4. ) Clinical stage I to IIIA ( AJCC-UICC TNM staging system ) ; 5. ) The maximum diameter of the lesion \< 5cm ; 6. ) physical condition score 0 or 1 ( Eastern Cooperative Oncology Group ECOG scoring system ) ; 7. ) Have not received any anti-thymoma therapy before, including but not limited to systemic chemotherapy, radiotherapy, etc. ; 8. ) Preoperative major organ function meets the following criteria : Bone marrow function: hemoglobin ≥ 10.0 g / dL ( no blood transfusion within 28 days before hemoglobin examination ), absolute neutrophil coun

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology